@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:result . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T19:37:57.660456"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "from using higher doses of dexamethasone" . rdf:OBJECT-POSITION rdfs:label "174"^^xsd:integer . rdf:PREDICATE rdfs:label "result" . rdf:PREDICATE-POSITION rdfs:label "[149]" . rdf:SUBJECT rdfs:label "dexamethasone-related complications" . rdf:SUBJECT-POSITION rdfs:label "102"^^xsd:integer . rdfs:ABSTRACT-UID ns2:50 "jw9huvy9" . rdfs:SENTENCE rdfs:label "In order to increase the therapeutic efficacy of dexamethasone in COVID-19 patients, while minimizing dexamethasone-related complications that could result from using higher doses of dexamethasone, we applied a chemocentric informatics approach to identify combination therapies." . rdfs:TRIPLE-UID ns3:jw9huvy9-TRIPLE-ABSTRACT-13 "jw9huvy9-TRIPLE-ABSTRACT-13" . rdfs:label "dexamethasone" . rdfs:label "doses" . } sub:pubInfo { sub:assertion prov:wasDerivedFrom . sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "IoWQzuVbn4IqPHJO0LewJ3y+wXyTDh1nKxgIiEepeH3dqrhIkK4QlRkTLKj8uF4n0N8jFGTJSdM7NyFh+KWoLY2VAkPyermj6zEjBIMxTrYHz8A61YpwxnC/O/uCaSbtc6gEgNzxgXqsqRS68fqsYgyM9lpotPV0DWtVpIPj09U="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T19:37:57.660456"^^xsd:dateTime; prov:wasAttributedTo . }